1. Articles from Andrew Bary

    1-7 of 7
    1. Warren Buffett Is Too Cautious; Berkshire Needs an Activist, Investor Says.

      Warren Buffett Is Too Cautious; Berkshire Needs an Activist, Investor Says.

      “Berkshire needs an activist,” says Bill Smead, the lead manager of the Smead Value fund, which counts Berkshire Hathaway among its top 10 holdings. Smead’s comments reflect the frustration of some Berkshire Hathaway shareholders who complain that CEO Warren Buffett has been too cautious during the recent market turmoil...

      Read Full Article
    2. Carl Icahn Is Right to Be Furious About Warren Buffett’s Sweet Occidental Petroleum Deal

      Carl Icahn Is Right to Be Furious About Warren Buffett’s Sweet Occidental Petroleum Deal

      Carl Icahn is seeing red. In a letter Monday blasting Occidental Petroleum ’s management and board, Icahn, the billionaire activist investor and Occidental shareholder, asserted that Warren Buffett took Occidental CEO Vicki Hollub “to the cleaners” when Occidental (ticker: OXY) agreed to issue $10 billion of preferred stock to Berkshire Hathaway (BRK.A) in late April. That preferred carries an 8% dividend yield, and Berkshire also got valuable warrants on Occidental stock...

      Read Full Article
    3. Bill Ackman Is Having His Best Year Ever. But Investors Ignore Pershing Square.

      Bill Ackman Is Having His Best Year Ever. But Investors Ignore Pershing Square.

      At age 53, the activist investor Bill Ackman is having the best year of his career . And for those who want to invest alongside him, there is now an opportunity to get in at a big discount. Ackman’s closed-end fund, Pershing Square Holdings (ticker PSH. Netherlands), closed Tuesday at $17.90 a share, a 28% discount to its net asset value of $24.92 on June 30...

      Read Full Article
    4. Carl Icahn Is Taking On Occidental Petroleum. Why That’s Good for the Stock.

      Carl Icahn Is Taking On Occidental Petroleum. Why That’s Good for the Stock.

      Carl Icahn’s latest target is Occidental Petroleum . He has blasted the company for its “hugely overpriced acquisition of Anadarko Petroleum ” and for disenfranchising shareholders by refusing to allow them to vote on the deal . While there is little the activist investor can do to stop the $38 billion acquisition, he is adding to the growing shareholder pressure on Occidental (ticker: OXY)—and that could be bullish for its depressed stock...

      Read Full Article
    1-7 of 7
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics in the News

    1. (13 articles) Board
    2. (10 articles) Board of directors
    3. (5 articles) Board of directors
    4. (4 articles) CEO
    5. (4 articles) Management
    6. (4 articles) Nasdaq
    7. (4 articles) Activist
    8. (3 articles) Bill Ackman
    9. (3 articles) Carl Icahn
    10. (3 articles) Square
    11. (3 articles) stake
    12. (3 articles) Investors
    13. (3 articles) CEO
    14. (3 articles) Management
    15. (3 articles) Investment
    16. (3 articles) Risk
    17. (3 articles) Companies
    18. (2 articles) Pershing Square Capital Management
    19. (2 articles) acquisition
    20. (2 articles) Investors
  3. Popular Articles

  4. Picture Gallery

    A New Low for Corporate Governance Will an Activist Ring Franklin's Bell? The Bill Ackman Comeback Picks Up Steam With a Recommendation Carl Icahn Is Taking On Occidental Petroleum. Why That’s Good for the Stock. Bill Ackman Is Having His Best Year Ever. But Investors Ignore Pershing Square. Carl Icahn Is Right to Be Furious About Warren Buffett’s Sweet Occidental Petroleum Deal Warren Buffett Is Too Cautious; Berkshire Needs an Activist, Investor Says. California Resources Corporation Announces Appointment of New Chair of the Board Praxis Precision Medicines Adds Development Expertise to Board of Directors with Appointment of Jeffrey Chodakewitz, M.D. Ancestry Appoints Gene Alston to its Board of Directors NN, Inc. Expands Board Of Directors With Appointment Of João Faria Ikena Oncology Appoints Dr. Maria Koehler to its Board of Directors